CR7568A - Metodos para tratar trastornos de dolor gastrointestinal y genitourinario mediante la vinlafaxina y sus derivados - Google Patents

Metodos para tratar trastornos de dolor gastrointestinal y genitourinario mediante la vinlafaxina y sus derivados

Info

Publication number
CR7568A
CR7568A CR7568A CR7568A CR7568A CR 7568 A CR7568 A CR 7568A CR 7568 A CR7568 A CR 7568A CR 7568 A CR7568 A CR 7568A CR 7568 A CR7568 A CR 7568A
Authority
CR
Costa Rica
Prior art keywords
vinlafaxine
derivatives
methods
pain disorders
treat gastrointestinal
Prior art date
Application number
CR7568A
Other languages
English (en)
Spanish (es)
Inventor
Mervyn Danilewitz
Robyn Gail Karlstadt
Richard Brian Lynn
Michael Scott Burton
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CR7568A publication Critical patent/CR7568A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CR7568A 2002-05-17 2004-11-04 Metodos para tratar trastornos de dolor gastrointestinal y genitourinario mediante la vinlafaxina y sus derivados CR7568A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38130502P 2002-05-17 2002-05-17

Publications (1)

Publication Number Publication Date
CR7568A true CR7568A (es) 2005-02-08

Family

ID=29550101

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7568A CR7568A (es) 2002-05-17 2004-11-04 Metodos para tratar trastornos de dolor gastrointestinal y genitourinario mediante la vinlafaxina y sus derivados

Country Status (21)

Country Link
US (1) US20040019101A1 (enExample)
EP (1) EP1505960A1 (enExample)
JP (1) JP2005530779A (enExample)
KR (1) KR20050003464A (enExample)
CN (1) CN1652758A (enExample)
AR (1) AR040033A1 (enExample)
AU (1) AU2003232137A1 (enExample)
BR (1) BR0310083A (enExample)
CA (1) CA2485736A1 (enExample)
CR (1) CR7568A (enExample)
EC (1) ECSP045436A (enExample)
IL (1) IL165216A0 (enExample)
MX (1) MXPA04011329A (enExample)
NO (1) NO20044868L (enExample)
NZ (1) NZ548950A (enExample)
RU (1) RU2004136999A (enExample)
SG (1) SG165991A1 (enExample)
TW (1) TW200402289A (enExample)
UA (1) UA81413C2 (enExample)
WO (1) WO2003097029A1 (enExample)
ZA (1) ZA200410157B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7419980B2 (en) * 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7524846B2 (en) * 2003-10-14 2009-04-28 Wyeth Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
US7550485B2 (en) * 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
US7402698B2 (en) * 2003-10-14 2008-07-22 Wyeth Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
US7531543B2 (en) * 2003-10-14 2009-05-12 Wyeth Phenylpiperazine cycloalkanol derivatives and methods of their use
US7365076B2 (en) * 2003-10-14 2008-04-29 Wyeth Substituted aryl cycloalkanol derivatives and methods of their use
US7491723B2 (en) * 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
US20070142367A1 (en) * 2003-11-10 2007-06-21 Lundeen James E Method and medicine for treating gastrointestinal disorder including fecal incontinence
US20060148782A1 (en) * 2003-11-10 2006-07-06 Lundeen James E Method and medicine for treating a mammal presenting urinary incontinence, urinary urgency, or both
US20060148783A1 (en) * 2003-11-10 2006-07-06 Lundeen James E Method and medicine for treating gastrointestinal disorder including fecal incontinence
US20050113365A1 (en) * 2003-11-10 2005-05-26 Sir Isaac Newton Enterprises Llc Method and medicine for treating gastrointestinal disorder including irritable bowel syndrome
US20060148781A1 (en) * 2003-11-10 2006-07-06 Lundeen James E Method and medicine for treating gastrointestinal disorder in a non-human mammal
US7820690B2 (en) * 2004-03-19 2010-10-26 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist
US7517899B2 (en) * 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
US7414052B2 (en) * 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
GB201007032D0 (en) * 2010-04-27 2010-06-09 Dormer Tools Ltd Twist drill for advanced materials
CN102095461B (zh) * 2011-01-18 2012-07-18 姚贤卿 复合型干度质量流量仪及干度标定测量方法
RU2740750C1 (ru) * 2020-03-27 2021-01-20 Аллан Герович Бениашвили Средство для лечения функциональных заболеваний желудочно-кишечного тракта

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
JP2000516198A (ja) * 1996-02-15 2000-12-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ セロトニンの再取り込み阻害剤の胃腸に対する作用を克服するための５ｈｔ４レセプター拮抗剤の使用
US6579899B1 (en) * 1998-07-16 2003-06-17 Massachusetts Institute Of Technology Composition for treatment of stress
US6121259A (en) * 1998-11-23 2000-09-19 Sepracor Inc. Olanzapine-N-oxide compositions and methods
CA2352611A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
JP2002530341A (ja) * 1998-11-23 2002-09-17 セプラコール， インク． デスメチルオランザピン組成物及び方法
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
GB2355191A (en) * 1999-10-12 2001-04-18 Laxdale Ltd Combination formulations for fatigue, head injury and strokes
MXPA04011529A (es) * 2002-04-24 2005-08-15 Cypress Bioscience Inc Prevencion y tratamiento de trastornos somaticos funcionales, incluyendo trastornos relacionados con la tension.
WO2003103603A2 (en) * 2002-06-10 2003-12-18 Wyeth Novel formate salt of o-desmethyl-venlafaxine

Also Published As

Publication number Publication date
US20040019101A1 (en) 2004-01-29
ECSP045436A (es) 2005-01-03
KR20050003464A (ko) 2005-01-10
WO2003097029A1 (en) 2003-11-27
ZA200410157B (en) 2006-05-31
IL165216A0 (en) 2005-12-18
UA81413C2 (en) 2008-01-10
AU2003232137A1 (en) 2003-12-02
CN1652758A (zh) 2005-08-10
TW200402289A (en) 2004-02-16
EP1505960A1 (en) 2005-02-16
CA2485736A1 (en) 2003-11-27
BR0310083A (pt) 2005-02-15
JP2005530779A (ja) 2005-10-13
NZ548950A (en) 2008-01-31
SG165991A1 (en) 2010-11-29
AR040033A1 (es) 2005-03-09
MXPA04011329A (es) 2005-02-14
NO20044868L (no) 2004-12-08
RU2004136999A (ru) 2006-06-10

Similar Documents

Publication Publication Date Title
DK1287364T3 (da) Diagnostisk og terapi til makulære degenerationsrelaterede lidelser
BR112015023747A2 (pt) métodos para tratar inflamação, doenças autoimunes e dor
CY1123296T1 (el) Μεθοδοι για τη διατροφικη διαχειριση του συνδρομου ευερεθιστου εντερου και της δυσαπορροφησης των υδατανθρακων
NO20081067L (no) Behandling med dihydropyndinkalsiumkanalblokkere og omega 3-fettsyrer, og et kombinasjonsprodukt derav
NO20091020L (no) Indol forbindelser
NO20082907L (no) Fremgangsmate for anvendelse av IL6 antagonister med proteasom-inhibitorer
CR9088A (es) Antagonistas del receptor 2 de citocina quimioatrayente de dipiperidina sustituida
EA200501867A1 (ru) Сочетание антагониста nmda-рецептора и селективного ингибитора обратного захвата серотонина для лечения депрессии и других психических расстройств
NO20080855L (no) Behandling med azetidinon-baserte kolesterol absorpsjonsinhibitorer og omega-3 fettsyrer og et kombinasjonsprodukt derav
PE20000954A1 (es) Composiciones farmaceuticas
PA8493701A1 (es) Compuestos para tratar la obesidad
EA201000673A1 (ru) СПОСОБЫ И КОМПОЗИЦИИ ДЛЯ ИЗМЕРЕНИЯ АКТИВАЦИИ Wnt И ДЛЯ ЛЕЧЕНИЯ Wnt-ОПОСРЕДОВАННЫХ РАКОВЫХ ЗАБОЛЕВАНИЙ
PL372372A1 (en) Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
NO20065847L (no) Difenylimidazopyrimidiner og -imidazolaminer som inhibitorer av B-sekretase
AR067903A1 (es) Metodo para tratar la depresion mediada por estres
EP1549336A4 (en) PREVENTING AND / OR TREATING INFLAMMATORY ENTERIC DISEASE USING YY PEPTIDES OR PEPTIDE YY ANTAGONISTS
BRPI0510142A (pt) compostos, composições e métodos para estabilizar a transtiretina e inibir a duplicação defeituosa da transtiretina
ECSP11010975A (es) Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales
UY38969A (es) Uso de inhibidores de sglt-2 en el secado de mamíferos no humanos
DK1429756T3 (da) Behandling af xanthoma med azetidinonderivater som sterolabsorptionsinhibitorer
DK1492561T3 (da) Fremgangsmåde til behandling af brystkirtellidelser
PA8597501A1 (es) Derivados azabiciclicos de piridiloximetilo y bencisoxazol
AR040795A1 (es) Intensifcador de la absorcion de calcio
AR058308A1 (es) Fragmentos vip y metodos de uso de los mismos
AR029134A1 (es) Metodos para el tratamiento o profilaxis de efectos patogenicos mediados por la aldosterona en un sujeto usando un antagonista de aldosterona epoxi esteroidal

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)